Metastasis-associated MCL1 and P16 copy number alterations dictate resistance to vemurafenib in a BRAFV600E patient-derived papillary thyroid carcinoma preclinical model
转移相关的 MCL1 和 P16 拷贝数变异决定了 BRAFV600E 患者来源的乳头状甲状腺癌临床前模型对维莫非尼的耐药性
期刊:Oncotarget
影响因子:
doi:10.18632/oncotarget.6442
Mark Duquette, Peter M Sadow, Amjad Husain, Jennifer N Sims, Zeus A Antonello, Andrew H Fischer, Chen Song, Elena Castellanos-Rizaldos, G Mike Makrigiorgos, Junichi Kurebayashi, Vania Nose, Paul Van Hummelen, Roderick T Bronson, Michelle Vinco, Thomas J Giordano, Dora Dias-Santagata, Pier Paolo Pand
